Skip to main content

Table 1 Characteristics of participants based on ATN classification

From: Dynamic changes of CSF clusterin levels across the Alzheimer’s disease continuum

Characteristics

A-(TN)-

A+(TN)-

A+(TN)+

A-(TN)+

P

N

50

39

147

40

 

Clinical diagnosis details (n, %)

CU

37(44.05)

13(15.48)

16(19.04)

18(21.43)

 

MCI

11(9.40)

6(5.13)

82(70.09)

18(15.38)

AD

2(2.67)

20(26.67)

49(65.33)

4(5.33)

Age (Mean ± SD, years)

74.53 ± 6.09

75.58 ± 5.23

74.66 ± 7.26

77.00 ± 7.46

0.232a

Gender (F/M)

19/31

12/27

61/86

17/23

1.000b

Education (Mean ± SD, years)

15.28 ± 3.01

15.51 ± 3.50

15.83 ± 2.93

16.10 ± 2.62

0.514a

APOE ε4 (n, %)

3 (6.00)

20 (51.28)

102 (69.39)

7 (17.50)

< 0.001b

MMSE score

28.44 ± 1.47

26.51 ± 2.45

25.69 ± 3.31

28.20 ± 1.74

< 0.001a

CSF biomarker

42 (pg/ml)

1441.64 ± 252.09

639.87 ± 194.49

587.76 ± 176.21

1794.03 ± 664.20

< 0.001a

t-tau (pg/ml)

191.10 ± 31.10

181.61 ± 33.97

353.71 ± 97.99

320.71 ± 81.04

< 0.001a

p-tau (pg/ml)

16.78 ± 2.87

16.66 ± 3.53

35.99 ± 10.63

29.09 ± 9.66

< 0.001a

Clusterin

20.56 ± 0.45

20.24 ± 0.45

20.38 ± 2.02

20.98 ± 0.36

< 0.001a

  1. Numbers and percentages are used to express categorical variables. Means ± SDs is used to express continuous variables.
  2. Abbreviations: CU Cognitively unimpaired, MCI Mild cognitive impairment, AD Alzheimer’s disease, F Female, M Male, APOE Apolipoprotein E, SD Standard deviations, MMSE Mini Mental State Examination, CSF cerebrospinal fluid, 42 amyloid-β 42, p-tau phosphorylated-tau, t-tau total-tau
  3. a Comparison of subgroups were employed by analyses of variance
  4. b Comparison of subgroups were employed by chi square